Simplex Trading
CBIO

Simplex Trading’s Crescent Biopharma CBIO Stock Holding History

Simplex Trading’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-343
Closed -$7K – 9038
2025
Q1 		$7K Sell
343
-89
-21% -$2.38K ﹤0.01% 7319
2024
Q4 		$10K Buy
+432
New +$11.8K ﹤0.01% 7181
2024
Q3 		– Sell
-2,417
Closed -$68K – 8888
2024
Q2 		$68K Buy
2,417
+1,518
+169% +$158K ﹤0.01% 5765
2024
Q1 		$269K Buy
899
+722
+408% +$216K ﹤0.01% 4530
2023
Q4 		$41K Sell
177
-35
-17% -$5.44K ﹤0.01% 6278
2023
Q3 		$31K Buy
212
+122
+136% +$19.2K ﹤0.01% 6222
2023
Q2 		$15K Sell
90
-1,027
-92% -$172K ﹤0.01% 7028
2023
Q1 		$140K Buy
1,117
+1,090
+4,037% +$245K ﹤0.01% 4761
2022
Q4 		$8K Buy
+27
New +$3.98K ﹤0.01% 7723
2022
Q2 		– Sell
-49
Closed -$5K – 10346
2022
Q1 		$5K Sell
49
-455
-90% -$53.4K ﹤0.01% 9409
2021
Q4 		$72K Buy
504
+225
+81% +$40.8K ﹤0.01% 6734
2021
Q3 		$64K Hold
279
– – ﹤0.01% 7215
2021
Q2 		$64K Buy
+279
New +$71K ﹤0.01% 7336
2021
Q1 		– Sell
-2
Closed -$716 – 7881
2020
Q4 		$93K Buy
2
+1
+100% +$350 ﹤0.01% 5510
2020
Q3 		$16K Buy
+1
New +$382 ﹤0.01% 6501
2020
Q2 		– Hold
0
– – – 7044
2020
Q1 		– Hold
0
– – – 7182
2019
Q4 		– Sell
-1
Closed -$541 – 5945
2019
Q3 		$27K Hold
1
– – ﹤0.01% 5571
2019
Q2 		$72K Buy
+1
New +$1.2K ﹤0.01% 4512
2019
Q1 		– Hold
0
– – – 6896
2018
Q3 		– Hold
0
– -$6K – 7627
2018
Q2 		– Hold
0
– – – 6614
2018
Q1 		– Hold
0
– – – 5261
2017
Q4 		– Hold
0
– – – 3806
2017
Q3 		– Hold
0
– -$1K – 6149
2017
Q2 		– Hold
0
– – – 5603

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Simplex Trading's CBIO Position: Q2 2024 in Review

Simplex Trading sold out of Crescent Biopharma (CBIO) in Q2 2024, closing a stake of 907 shares — an estimated $94.3K sold.

Simplex Trading first reported a position in CBIO in Q2 2017 and held it in 20 quarters. The position peaked at $280K in Q1 2019. 35 funds tracked by Wall St. Rank hold CBIO as of Q2 2024.

  • Simplex Trading reported no remaining Crescent Biopharma position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 907 Crescent Biopharma shares in Q2 2024, an estimated $94.3K.
  • Simplex Trading first reported a position in Crescent Biopharma in Q2 2017 and held it in 20 quarters.
  • Simplex Trading's Crescent Biopharma position peaked at $280K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.